SS

Shailesh Shankarlal Bhavsar

Active Director Director DIN 08003467
DIN 08003467 First appointment Dec 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Shankarlal Bhavsar

Data last updated:

Shailesh Shankarlal Bhavsar is a Director at Unsullied Pharma Private Limited (since 2017). The company operates in Pharma.

DIN 08003467
Primary Designation Director
Industry Pharma
First Appointment 12 Dec 2017
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unsullied Pharma Private Limited U51909GJ2017PTC100116
Director12 Dec 20172017Active

Board colleagues of Shailesh Shankarlal Bhavsar

NameDINCompanyDesignation
Hansaben Maheshbhai Patoliya08003413Unsullied Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Unsullied Pharma Private Limited
Premium access

Shareholding and investment profile for Shailesh Shankarlal Bhavsar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Shankarlal Bhavsar

Shailesh Shankarlal Bhavsar currently holds 1 directorship: Unsullied Pharma Private Limited (Director, since 12 Dec 2017).

Shailesh Shankarlal Bhavsar was first appointed on 12 Dec 2017 as Director at Unsullied Pharma Private Limited.

The current boards of Shailesh Shankarlal Bhavsar's companies include Hansaben Maheshbhai Patoliya (Unsullied Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available